1. Digital Pathology Market – Overview
1.1 Definitions and Scope
2. Digital Pathology Market – Executive Summary
2.1 Market Revenue and Key Trends
2.2 Key trends by Product
2.3 Key trends by Type
2.4 Key trends by Geography
3. Digital Pathology Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis- Average Selling Price
4. Digital Pathology Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Digital Pathology Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Digital Pathology Market – By Product(Market Size –$Million/$Billion)
6.1 Scanners
6.2 Software
6.3 Communication Systems
6.4 Storage Systems
7. Digital Pathology Market – By Type (Market Size –$Million/$Billion)
7.1 Human Pathology
7.2 Veterinary Pathology
8. Digital Pathology Market – By Application (Market Size –$Million/$Billion)
8.1 Drug Discovery
8.2 Disease Diagnosis
8.3 Teleconsultation
8.4 Training & Education
9. Digital Pathology Market – By End User(Market Size –$Million/$Billion)
9.1 Pharmaceutical & Biotechnology Companies
9.2 Hospitals and Reference Laboratories
9.3 Academic & Research Institutes
10. Digital Pathology Market – By Geography(Market Size –$Million/$Billion)
10.1 North America
10.1.1 U.S.
10.1.2 Mexico
10.1.3 Canada
10.2 Europe
10.2.1 U.K.
10.2.2 France
10.2.3 Germany
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 India
10.3.3 Japan
10.3.4 South Korea
10.3.5 Australia & New Zealand
10.3.6 Rest of APAC
10.4 South America
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Others
10.5 Rest of the World
10.5.1 Middle East
10.5.2 Africa
11. Digital Pathology Market – Entropy
12. Digital Pathology Market Company Analysis (Company Revenue, Product, M&A, Developments)
12.1 Company 1
12.2 Company 2
12.3 Company 3
12.4 Company 4
12.5 Company 5
12.6 Company 6
12.7 Company 7
12.8 Company 8
12.9 Company 9
12.10 Company 10
“*Financials for private companies would be provided on a best efforts basis”.
Report Description
Overview
이 보고서는 디지털 병리학의 성장 가능성과 주요 응용 분야를 분석한 글로벌 시장 보고서입니다. 디지털 스캐너와 소프트웨어가 주로 사용됩니다.
Segment
제품은 스캐너, 소프트웨어, 커뮤니케이션 시스템 및 스토리지 시스템으로 나뉩니다. 주요 응용 분야는 약물 개발, 질병 진단, 원격 상담 등이 있습니다.
Key Takeaways
원격 진단 수요 증가와 기술 발전이 시장을 촉진하며, 초기 도입 비용이 주요 제약 요인으로 작용합니다.